Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
LY2484595
.
Show all posts
Showing posts with label
LY2484595
.
Show all posts
Monday, May 4, 2015
Eli Lilly accepts committee recommendation to extend evacetrapib Phase 3 trial
›
We know that, Evacetrapib is a drug under development by Eli Lilly and company (investigational name LY2484595 ) ...
›
Home
View web version
